血管紧张素转换酶浓度升高与活性缺失与儿童脓毒性休克不良肾脏结局相关
该先导研究纳入现有多中心观察性研究中72例1周至18岁脓毒性休克患儿,测定第1天血清ACE浓度与活性,并分析其与复合结局(第1-7天严重持续性AKI、肾脏替代治疗或死亡)的关联。50/72(69%)患儿ACE活性缺失(<2.41 U/L),27/72(38%)发生复合结局。发生复合结局者ACE活性缺失比例更高(85% vs 65%,p=0.025),第1天肾素+肾素原更高(16,774 vs 3,037 pg/ml,p<0.001),ACE浓度更高(149 vs 96 pg/ml,p=0.019)。多因素回归中ACE浓度升高(aOR 1.01,95%CI 1.002-1.03,p=0.015)与ACE活性缺失(aOR 6.6,95%CI 1.2-36.1,p=0.031)与复合结局独立相关。作者认为需在更大队列中验证。
要点
- 儿童脓毒性休克第1天69%(50/72)ACE活性缺失(<2.41 U/L),38%(27/72)发生复合不良肾脏结局。
- 发生复合结局者ACE活性缺失比例更高(85% vs 65%,p=0.025),第1天肾素+肾素原更高(16,774 vs 3,037 pg/ml,p<0.001),ACE浓度更高(149 vs 96 pg/ml,p=0.019)。
- 多因素回归中ACE活性缺失与复合结局独立相关(aOR 6.6,95%CI 1.2-36.1,p=0.031)。
- 多因素回归中ACE浓度升高与复合结局独立相关(aOR 1.01,95%CI 1.002-1.03,p=0.015)。
- ACE活性缺失者第1天肾素+肾素原高于有活性者(4,533 vs 2,227 pg/ml,p=0.017),两组ACE浓度无差异。
适用人群与场景
- 年龄1周至18岁的儿童脓毒性休克患者,来自现有多中心观察性研究。
诊断标准与关键阈值
- ACE活性缺失定义为血清ACE活性<2.41 U/L。
- 复合结局包括第1-7天严重持续性AKI、使用肾脏替代治疗或死亡。
研究设计与关键结果
- 先导研究纳入72例患儿,第1天50/72(69%)ACE活性缺失(<2.41 U/L),27/72(38%)发生复合结局。
- ACE活性缺失者第1天肾素+肾素原高于有活性者(4,533 vs 2,227 pg/ml,p=0.017),两组ACE浓度无差异。
- 发生复合结局者较未发生者更常见ACE活性缺失(85% vs 65%,p=0.025),第1天肾素+肾素原更高(16,774 vs 3,037 pg/ml,p<0.001),ACE浓度更高(149 vs 96 pg/ml,p=0.019)。
- 多因素回归中,ACE浓度升高(aOR 1.01,95%CI 1.002-1.03,p=0.015)与ACE活性缺失(aOR 6.6,95%CI 1.2-36.1,p=0.031)与复合结局独立相关。
证据类型、等级与局限
- 证据类型:先导研究,样本来自现有多中心观察性研究,共72例。
- 局限:作者指出需在更大队列中进一步研究以验证这些发现。
对床旁实践的改变
- 在儿童脓毒性休克中,第1天ACE活性缺失(<2.41 U/L)与不良肾脏结局独立相关(aOR 6.6),ACE浓度升高亦相关(aOR 1.01),提示ACE/RAAS轴可能作为风险分层标志;作者认为需在更大队列中验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis-induced endothelial dysfunction is proposed to cause angiotensin-converting enzyme (ACE) dysfunction and renin-angiotensin-aldosterone system (RAAS) derangement, exacerbating vasodilatory shock and acute kidney injury (AKI). Few studies test this hypothesis directly, including none in children. We measured serum ACE concentrations and activity, and assessed their association with adverse kidney outcomes in pediatric septic shock.
METHODS: A pilot study of 72 subjects aged 1 week-18 years from an existing multicenter, observational study. Serum ACE concentrations and activity were measured on Day 1; renin + prorenin concentrations were available from a previous study. The associations between individual RAAS components and a composite outcome (Day 1-7 severe persistent AKI, kidney replacement therapy use, or mortality) were assessed.
RESULTS: 50/72 subjects (69%) had undetectable ACE activity (< 2.41 U/L) on Day 1 and 27/72 (38%) developed the composite outcome. Subjects with undetectable ACE activity had higher Day 1 renin + prorenin compared to those with activity (4533 vs. 2227 pg/ml, p = 0.017); ACE concentrations were no different between groups. Children with the composite outcome more commonly had undetectable ACE activity (85% vs. 65%, p = 0.025), and had higher Day 1 renin + prorenin (16,774 pg/ml vs. 3037 pg/ml, p < 0.001) and ACE concentrations (149 vs. 96 pg/ml, p = 0.019). On multivariable regression, increasing ACE concentrations (aOR 1.01, 95%CI 1.002-1.03, p = 0.015) and undetectable ACE activity (aOR 6.6, 95%CI 1.2-36.1, p = 0.031) retained associations with the composite outcome.
CONCLUSIONS: ACE activity is diminished in pediatric septic shock, appears uncoupled from ACE concentrations, and is associated with adverse kidney outcomes. Further study is needed to validate these findings in larger cohorts.
参考来源
- Pode-Shakked N, Ceschia G, Rose JE, et al. Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock. Crit Care. 2023. PMID: 37308975. doi:10.1186/s13054-023-04518-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。